We are live on ! Find out more
CPIX icon

Cumberland Pharmaceuticals
CPIX

28 hedge funds and large institutions have $11.4M invested in Cumberland Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

4% more funds holding

Funds holding: 27 → 28 (+1)

0.82% less ownership

Funds ownership: 26.62% → 25.81% (-0.82%)

12% less capital invested

Capital invested by funds: $12.9M → $11.4M (-$1.51M)

44% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 9

Holders
28
Holders Change
+1
Holders Change %
+3.7%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BAM
Berkshire Asset Management
Pennsylvania
+$501K
2
Renaissance Technologies
Renaissance Technologies
New York
+$229K
3
AI
Ariel Investments
Illinois
+$117K
4
PPA
Parametric Portfolio Associates
Washington
+$4.89K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.26K

Top Sellers

Rank Fund Capital Flow
1
SCM
Stonepine Capital Management
Oregon
-$1.21M
2
BCM
Bridgeway Capital Management
Texas
-$96K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$51.7K
4
Morgan Stanley
Morgan Stanley
New York
-$11.1K
5
BlackRock
BlackRock
New York
-$7.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
Ariel Investments
Illinois
$2.42M +$117K +38,655 +5%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$2.3M -$51.7K -17,063 -2%
Renaissance Technologies
3
Renaissance Technologies
New York
$1.99M +$229K +75,501 +13%
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.16M -$300 -99 -0%
BlackRock
5
BlackRock
New York
$1.07M -$7.76K -2,563 -0.7%
SCM
6
Stonepine Capital Management
Oregon
$557K -$1.21M -400,794 -68%
BAM
7
Berkshire Asset Management
Pennsylvania
$488K +$501K +165,495 New
BCM
8
Bridgeway Capital Management
Texas
$445K -$96K -31,713 -17%
Acadian Asset Management
9
Acadian Asset Management
Massachusetts
$310K – – –
California Public Employees Retirement System
10
California Public Employees Retirement System
California
$157K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$151K – – –
SFP
12
Sterling Financial Planning
New Jersey
$65K +$66.7K +22,031 New
Northern Trust
13
Northern Trust
Illinois
$64K -$3.81K -1,259 -5%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$60K – – –
PPA
15
Parametric Portfolio Associates
Washington
$49K +$4.89K +1,617 +11%
UCFA
16
United Capital Financial Advisors
Texas
$48K – – –
Cambridge Investment Research Advisors
17
Cambridge Investment Research Advisors
Iowa
$30K – – –
Russell Investments Group
18
Russell Investments Group
United Kingdom
$15K – – –
Morgan Stanley
19
Morgan Stanley
New York
$14K -$11.1K -3,677 -43%
TRCT
20
Tower Research Capital (TRC)
New York
$13K +$4.26K +1,408 +43%
OC
21
Oakworth Capital
Alabama
$9K – – –
UBS Group
22
UBS Group
Switzerland
$6K -$312 -103 -5%
Osaic Holdings
23
Osaic Holdings
Arizona
$2K +$817 +270 +59%
PAM
24
Panagora Asset Management
Massachusetts
$1K -$279 -92 -16%
Fidelity Investments
25
Fidelity Investments
Massachusetts
$1K – – –
1
2

CPIX Hedge Fund Activity: Q4 2020 in Review

28 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q4 2020, worth a combined $11.4M — down 12% from $12.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CPIX positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 9 trimmed.

The largest buyer was Berkshire Asset Management, opening a new position worth an estimated $501K. The largest seller was Stonepine Capital Management, cutting an estimated $1.21M.

  • 28 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q4 2020, up from 27 in Q3 2020.
  • Funds reported $11.4M of Cumberland Pharmaceuticals stock for Q4 2020, down 12% quarter-over-quarter.
  • 3 funds opened new Cumberland Pharmaceuticals positions in Q4 2020 and 2 closed out, a net change of +1 holder.
  • The largest Cumberland Pharmaceuticals buyer in Q4 2020 was Berkshire Asset Management, an estimated $501K added.
  • The largest Cumberland Pharmaceuticals seller in Q4 2020 was Stonepine Capital Management, an estimated $1.21M sold.

Based on aggregated 13F filings for Q4 2020.